Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Sul AR et al. | 2006 | intact cell/cell culture, hFOB 1.19 (human fetal osteoblasts), T/G HA-VSMC (human aortic vascular smooth muscle cells), RPMI 7666 (human B lymphoblasts) and HCN-2 (human cortical neuronal cells) | magnetic field, 50/60 Hz | 2 mT |
Novak J et al. | 2007 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>) | magnetic field, 50/60 Hz | 5.2–10 mT |
Guo H et al. | 2004 | intact cell/cell culture, SNU cells (human gastric adenocarcinoma cell line) | magnetic field, 50/60 Hz | 97 mT |
Revoltella RP et al. | 1993 | intact cell/cell culture, Friend erythroleukemia cell line (line 3BM-78, clone H19 from line 5-86, line 707M, clone F4-1 from line F4-N) | magnetic field, 50/60 Hz | 200 µT |
Rodriguez de la Fuente AO et al. | 2008 | protozoa, <i>Entamoeba invadens</i> | magnetic field, 50/60 Hz | 1–2 mT |
Vianale G et al. | 2008 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz | 1 mT |
Ruiz-Gomez MJ et al. | 2008 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>)/WS8105-1C | magnetic field, 50/60 Hz | 2.45 mT |
Glück B et al. | 2001 | intact cell/cell culture, U937 (human leukemic monocyte cell line) | magnetic field, 50/60 Hz | 0.3–4.5 mT |
Ruiz-Gomez MJ et al. | 2010 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>)/wild type (WS8105-1C) and <i>rad52 hdf1</i> mutants (<i>rad52</i>, <i>hdf1</i>, <i>rad52 hdf1</i>; radiation sensitive 52, high affinity DNA binding factor 1) | magnetic field, 50/60 Hz | 2.45 mT |
Sulpizio M et al. | 2011 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.